We make a wide range of prescription medicines, vaccines and consumer healthcare products
Explore our three business area portfolios for more information. We list many – but not all – of our products across a wide range of countries on the following pages.
Our prescription medicines
Our pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the world's most common acute and chronic diseases
Our vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across over 150 countries
In March 2015 we completed a 3-part transaction with Novartis which reshaped our business.
We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our consumer healthcare businesses to create a new company.
In addition, Novartis acquired our marketed Oncology portfolio and the R&D activities related to it.